Hungarian biometrics firm BioSec Group has entered a new deal with Japanese tech firm Fujitsu.In a statement, BioSec said the partnership focuses on BioSec's palm vein recognition based security solutions, which will be available in the Fujitsu product portfolio, including BioSec's physical access control-, IT security- and stadium security solutions.Part of the agreement is that Fujitsu will sell BioSec solutions in the EMEIA region, where there is a significant interest for innovative high security technology, such as biometrics, which provides a convenient alternative for passwords, PIN codes, keys, cards and tokens, just to mention a few. The magic behind biometrics is that it is something the user is, therefore people do not have to remember complicated passwords or searching for keys and access cards all the time.According to BioSec: “As people are getting more familiar with biometric solutions, they see that there is great difference between technologies. Even fingerprint recognition is the most widely adopted technology currently, it is not necessarily the most secure one. There is no 100% security solution of course, but palm vein recognition is quite close to it.”BioSec noted that it has been developing biometric solutions based on Fujitsu's PalmSecure technology for almost a decade.
Recent Video
- New non-profit trade association of HAND will standardise global talent ID
- No cards, no phones: J.P. Morgan’s biometric revolution in payments
- Anthony Vidiano on building the future of access management
- Charisma Check wins 2025 Start-Up Pitching Competition, advancing identity verification and background checks for dating app users
- How to protect one billion Amazon customers: Lessons from continuous risk assessments
